Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)

Abstract Background Galcanezumab is approved in the European Union (EU) as migraine prophylaxis in adults with at least four migraine days per month. The aim of this retrospective observational study was to evaluate the long-term effectiveness of galcanezumab on migraine-related burdens and its impa...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, Antonio Russo, Piero Barbanti, Grazia Sances, Sabina Cevoli, Renata Rao, Carlo Lovati, Anna Ambrosini, Carlotta Buzzoni, Federico Battisti, Laura Vatteone, Steffy Martin Luther King, Federico Torelli
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Adis, Springer Healthcare 2024-02-01
Cyfres:	Neurology and Therapy
Pynciau:	Galcanezumab Migraine Migraine prevention Calcitonin gene-related peptide Monoclonal antibodies Long-term treatment
Mynediad Ar-lein:	https://doi.org/10.1007/s40120-024-00582-0
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!